Loading NVST…
NVST • CIK 0001757073
Overview Envista is a global family of more than 30 trusted dental brands, including Nobel Biocare, Ormco, DEXIS, and Kerr, united by a shared purpose: to partner with professionals to improve lives. We help our customers deliver the best possible patient care through industry-leading products, solutions, and technology. Our comprehensive portfolio, including dental implants and treatment options, orthodontics, and digital imaging technologies, covers a wide range of dentists' clinical needs for diagnosing, treating, and preventing dental conditions as well as improving the human smile. We further support the dental community with leading solutions in restoratives, endodontics, rotary, infection prevention, and loupes. We were formed in 2018 as a wholly-owned subsidiary of Danaher Corporation. In 2019, we completed our initial public offering and separated from Danaher Corporation. With a foundation comprised of the proven Envista Business System (“EBS”) methodology, an experienced leadership team, and a strong culture grounded in continuous improvement, commitment to innovation, and deep customer focus, we are well equipped to meet the end-to-end needs of dental professionals worldwide. We are one of the largest global dental products companies, with strong positions in some of the most attractive segments of the dental products industry. We serve dental professionals in over 130 countries through one of the largest commercial organizations in the dental products industry and through our distribution partners. In 2025, we generated total sales of $2.7 billion, of which approximately 85% were derived from sales of consumable products, services, and spare parts. Our business is operated through two segments: Specialty Products & Technologies, which is comprised of our Dental Implant Solutions and Orthodontic Solutions businesses, and Equipment & Consumables , which is comprised of our Diagnostic and Consumables Solutions businesses. The following table presents the Company’s revenues disaggregated by geographical region for the years ended December 31, 2025 and 2024 ($ in millions). Specialty Products & Technologies Equipment & Consumables Total Year ended December 31, 2025 Geographical region: North America (U.S. and Canada) $ 720.5 $ 674.7 $ 1,395.2 Western Europe 498.0 117.3 615.3 Other developed markets 89.5 33.3 122.8 Emerging markets 444.8 141.4 586.2 Total $ 1,752.8 $ 966.7 $ 2,719.5 Year ended December 31, 2024 Geographical region: North America (U.S. and Canada) $ 684.0 $ 621.3 $ 1,305.3 Western Europe 439.4 106.6 546.0 Other developed markets 86.1 34.2 120.3 Emerging markets 406.9 132.1 539.0 Total $ 1,616.4 $ 894.2 $ 2,510.6 2 Our Business Segments The table below describes the percentage of our total annual sales attributable to each of our segments over each of the three years ended December 31. For additional information regarding sales, operating profit and identifiable assets by segment, please refer to Note 21 in our Consolidated Financial Statements included elsewhere in this Annual Report. 2025 2024 2023 Specialty Products & Technologies 64% 64% 64% Equipment & Consumables 36% 36% 36% Specialty Products & Technologies Our Specialty Products & Technologies segment primarily develops, manufactures and markets dental implant systems, including regenerative solutions, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, lab products, and loupes. We typically market these products directly to end-users through our commercial organization, and 84% of our 2025 sales for this segment were direct sales. In 2025, our Specialty Products & Technologies segment generated $1,752.8 million of sales, representing year-over-year sales and core sales increase of 8.4% and 6.3%, respectively. In 2025, 41% of segment sales were derived from North America, 28% from Western Europe, 5% from other developed markets, and 26% from emerging markets. Sales of consumable products, services and spare parts comprised 93% of segment sales in 2025. We believe strong industry fundamentals and the introduction of new product solutions in this segment will continue to drive growth for us. Dental Implant Solutions We are a world leader in the field of innovative Dental Implant Solutions, offering a full portfolio of solutions that enable dentists to deliver single-tooth to full-mouth restorations.…
From recent Form 4 filings